Global Biopharmaceutical Leader Starpharma Holdings is a global leader in biopharmaceuticals with a focus on innovative polymers for pharmaceutical and medical product development. This positions the company well to attract international partners and expand its market reach.
Cutting-Edge Technology Stack Starpharma utilizes a cutting-edge technology stack including Google Analytics, Amazon Web Services, and jQuery among others. This tech-savvy approach enhances operational efficiency and offers opportunities for collaboration with tech-focused clients.
Strong Financial Backing With a revenue ranging between $0 - 10M and recent funding of $32M, Starpharma demonstrates financial stability and growth potential. This financial health can attract investors and partners seeking profitable collaborations.
Market Expansion Opportunities Given the company's positioning in the biotechnology research industry and potential for innovative product development, there are significant opportunities for market expansion into new therapeutic areas and geographical regions, presenting lucrative sales possibilities.
Competitive Benchmarking Insights Comparing to similar companies like PCAS, Catalent Pharma Solutions, and Jazz Pharmaceuticals in terms of employee size and revenue, Starpharma stands out as a mid-sized player with room for growth and a competitive edge in niche pharmaceutical segments.
Starpharma uses 8 technology products and services including Google Analytics, Font Awesome, Mustache, and more. Explore Starpharma's tech stack below.
| Starpharma Email Formats | Percentage |
| First.Last@starpharma.com | 45% |
| Last@starpharma.com | 7% |
| FirstLast@starpharma.com | 3% |
| First.Last@starpharma.com | 45% |
Biotechnology ResearchVictoria, Australia51-200 Employees
Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for respiratory viruses, DEP® drug delivery and VivaGel®.
Company Overview
Funding & FinancialsStarpharma has raised a total of $32M of funding over 1 rounds. Their latest funding round was raised on Sep 30, 2020 in the amount of $32M.
Starpharma's revenue is in the range of $10M
Funding & FinancialsStarpharma has raised a total of $32M of funding over 1 rounds. Their latest funding round was raised on Sep 30, 2020 in the amount of $32M.
Starpharma's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com